OXT and Huntington disease: A recent controlled clinical trial consisting of 9 non-medicated males with CAG-expansion HD and 10 age-matched healthy controls provide evidence that intranasal oxytocin normalizes abnormal brain activity measured by functional MRI (fMRI) in the HD patients to levels similar to controls.